Drug-makers Amgen and Johnson & Johnson are voluntarily recalling two brands of an injectable anemia medication because of the possibility that vials of it may also contain tiny glass flakes. The drug, Epoetin alfa, is marketed…
Novartis (NVS) agreed to sell the U.S. rights to bladder medicine Enablex for $400 million.
Ireland-based Warner Chilcott will take over the marketing, sales and manufacturing of the drug in the United States, Novartis said in a statement. The deal is expected to close by the end of October.
Novartis may also receive “milestone payments” of as much as $20 million.
In 2005, Novartis…
Continue reading Novartis Sells U.S. Rights to Enablex for $400 Million
Novartis Sells U.S. Rights to Enablex for $400 Million originally appeared on DailyFinance on Fri, 24 Sep 2010 06:46:00.
Filed Under: Company News, Health Care, Novartis, Insurance, Retail
GlaxoSmithKline’s Avandia diabetes drug got hit with a double whammy from regulators on both sides of the pond Thursday. The European Medicines Agency announced plans to yank the drug from the market in the coming months, while…
Rite Aid Corporation (RAD) announced a quarterly loss of 23 cents per diluted share, compared to a loss of 14 cents per share a year earlier, thanks to refinancing costs and falling revenues.
Revenue for the quarter ending Aug. 28 was $6.2 billion, compared with $6.3 billion a year earlier, the company said in a statement. Same store sales fell 1.5%.
The net loss included a charge…
Continue reading Rite Aid Earnings Highlight Another Rough Quarter
Rite Aid Earnings Highlight Another Rough Quarter originally appeared on DailyFinance on Thu, 23 Sep 2010 08:16:00.
Filed Under: Company News, Economy, Health Care, Retail
Republicans in the House of Representatives promised to end “job-killing tax hikes” and repeal the health reform law as part of their campaign manifesto for the November election.
In their “Pledge to America,” House Republicans also say they will ban…